Evidence map›Paper›PMID 33209438›Full record

ReviewJournal of thoracic disease2020

Alternative methods of lymph node staging in lung cancer: a narrative review.

Marcin M Cackowski, Grzegorz M Gryszko, Marcin Zbytniewski, Dariusz A Dziedzic, Tadeusz M Orłowski

Open access · diamondAbstract readReview
In one paragraph

Review in Journal of thoracic disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Marcin M CackowskiDepartment of Thoracic Surgery, National Research Institute of Chest Diseases, Warsaw, Poland.
Grzegorz M GryszkoDepartment of Thoracic Surgery, National Research Institute of Chest Diseases, Warsaw, Poland.
Marcin ZbytniewskiDepartment of Thoracic Surgery, National Research Institute of Chest Diseases, Warsaw, Poland.
Dariusz A DziedzicDepartment of Thoracic Surgery, National Research Institute of Chest Diseases, Warsaw, Poland.
Tadeusz M OrłowskiDepartment of Thoracic Surgery, National Research Institute of Chest Diseases, Warsaw, Poland.
Narodowy Instytut Leków · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The nodal status indicator in non-small cell lung cancer is one of the most crucial prognostic factors available. However, there are still many arguments among scientists regarding whether the currently used nodal status descriptor should be changed in the forthcoming editions of the Tumor Node Metastasis classification or whether it is precise enough and should be maintained as is. We reviewed studies concerning nodal factor classifications to evaluate their accuracy in non-small cell lung cancer patients and to address the previously mentioned challenge. We reviewed the PubMed database regarding the following classifications: ongoing 8

Indexed as

Lung cancerlymphadenectomynodal stagingreview

Identifiers

PMID33209438
PMCPMC7656442
OpenAlexW3090827850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.